@OpenAI: Introducing GPT-Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and tr…
Summary
OpenAI introduces GPT-Rosalind, a frontier reasoning model specifically designed to support research in biology, drug discovery, and translational medicine.
View Cached Full Text
Cached at: 04/20/26, 09:39 AM
Introducing GPT-Rosalind, our frontier reasoning model built to support research across biology, drug discovery, and translational medicine.
Similar Articles
Introducing GPT-Rosalind for life sciences research
OpenAI introduces GPT-Rosalind, a frontier reasoning model designed to accelerate research in biology, drug discovery, and translational medicine by optimizing scientific workflows and tool usage.
@OpenAI: GPT-Rosalind, our Life Sciences model series, is optimized for scientific workflows, with stronger performance in prote…
OpenAI releases GPT-Rosalind, a specialized life sciences model optimized for protein reasoning, chemical analysis, genomics, and scientific workflows.
Introducing new capabilities to GPT-Rosalind
OpenAI introduces an updated GPT-Rosalind model purpose-built for life sciences research, with improved performance in medicinal chemistry, genomics, and drug-discovery workflows, and new benchmarks like LifeSciBench and MedChemBench.
Biodefense in the Intelligence Age
OpenAI announces a biodefense action plan alongside GPT-Rosalind, a frontier reasoning model for biology and drug discovery, and Rosalind Biodefense, aimed at equipping trusted developers with AI-powered tools for biological security and pandemic preparedness.
Turning scattered evidence into discovery decisions for life sciences
OpenAI’s new life-science model “GPT-Rosalind” inside Codex autonomously ranks asthma drug targets by orchestrating specialist sub-agents that merge genetics, transcriptomics, safety and IP data into a single evidence-backed decision.